Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-26250

ABSTRACT: Expression data of MCF7/ADR cells treated with MC70, an ABC transporters inhibitor

OTHER RELATED OMICS DATASETS IN: PRJNA135081

PROVIDER: E-GEOD-26250 | ExpressionAtlas | 2015-08-12

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-26250-analysis-methods.tsv	Tabular
	E-GEOD-26250-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-26250-configuration.xml	Xml
	E-GEOD-26250-percentile-ranks.tsv	Tabular
	E-GEOD-26250.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 80

Similar Datasets

Homo sapiens

Project description:Expression data from MCF7 and MCF7-LTED cells treated with YC-1

| PRJNA169021 | ENA

Antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells

2011-01-29 | GSE19777 | GEO

CREBBP/EP300 acetyltransferase inhibition targets lineage specific enhancers to inhibit the proliferation of ER+ breast cancer cells [ATAC-Seq]

Project description:MCF7 cells were treated with a CREBBP/EP300 acetyltransferase inhibitor CPI-1612 and chromatin status was measured via ATAC-seq

2022-03-04 | GSE190159 | GEO

CREBBP/EP300 acetyltransferase inhibition targets lineage specific enhancers to inhibit the proliferation of ER+ breast cancer cells [scATAC-Seq]

Project description:MCF7 cells were treated with a CREBBP/EP300 acetyltransferase inhibitor CPI-1612 and chromatin status was measured via single-cell ATAC-seq

2022-03-04 | GSE190162 | GEO

Homo sapiens

Project description:Expression data from MCF7 cells treated with RITA or Nutlin

| PRJNA342816 | ENA

CREBBP/EP300 acetyltransferase inhibition targets lineage specific enhancers to inhibit the proliferation of ER+ breast cancer cells [RNA-Seq]

Project description:MCF7, T47D, or ZR751 cells were treated with a CREBBP/EP300 acetyltransferase inhibitor CPI-1612 and/or Fulvestrant and expression changes were measured via RNA-seq

2022-03-04 | GSE190160 | GEO

Homo sapiens

Project description:MCF7 inhibitor

| PRJNA98795 | ENA

Antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells

Project description:Full title: Expression data from antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells The expression of miR-221/222 were found to be upregulated in fulvestrant resistant breast cancer cells MCF7-FR compared to its drug-sensitive counterpart MCF7. To investigate the role of miR-221/222 in acquired resistance to fulvestrant, we lowered the level of miR-221/222 in MCF7-FR cells using miRNA inhibitors (antagomirs), and compared gene expression profiles before and after treatment. Fulvestrant-resistant breast cancer cells MCF7-FR (originated from drug-sentitive breast cancer model cell line MCF7) were transient-transfected by antigomirs targeting miR221 or miR222 (i.e. si221, si222). All three cell lines, MCF7-FR, siR221, siRNA222 were subjected to gene expression profiling.

2011-01-29 | E-GEOD-19777 | biostudies-arrayexpress

Expression data in LoVo cells treated with MEK inhibitor

Project description:Expression data in LoVo cells treated with MEK inhibitor

| PRJNA422292 | ENA

Homo sapiens

Project description:Expression data of A939572 SCD1 inhibitor treated ccRCC cells

| PRJNA177176 | ENA